133 related articles for article (PubMed ID: 11272601)
41. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
42. Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
Mori T; Kikuchi T; Koh M; Koda Y; Yamazaki R; Sakurai M; Tomita Y; Ozawa Y; Kohashi S; Abe R; Saburi M; Kato J
Bone Marrow Transplant; 2021 Jun; 56(6):1266-1271. PubMed ID: 33311594
[TBL] [Abstract][Full Text] [Related]
43. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
[TBL] [Abstract][Full Text] [Related]
44. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
45. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
[TBL] [Abstract][Full Text] [Related]
46. [Resistant cytomegalovirus infection in related donor kidney allograft recipients].
Goryainov VA; Kaabak MM; Babenko NN; Platova EN; Aganesov AG; Morozova MM; Panin VV
Ter Arkh; 2016; 88(6):73-76. PubMed ID: 27296265
[TBL] [Abstract][Full Text] [Related]
47. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
48. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients.
Toyoda M; Puliyanda DP; Amet N; Baden L; Cam V; Radha R; Pao A; Vo A; Bunnapradist S; Moudgil A; Jordan SC
Transplantation; 2005 Jul; 80(2):198-205. PubMed ID: 16041264
[TBL] [Abstract][Full Text] [Related]
49. CMV infection, diagnosis and antiviral strategies after liver transplantation.
Lautenschlager I
Transpl Int; 2009 Nov; 22(11):1031-40. PubMed ID: 19619175
[TBL] [Abstract][Full Text] [Related]
50. A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments.
Boivin G; Gilbert C; Morissette M; Handfield J; Goyette N; Bergeron MG
AIDS; 1997 Jun; 11(7):867-73. PubMed ID: 9189211
[TBL] [Abstract][Full Text] [Related]
51. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
52. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Noble S; Faulds D
Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
[TBL] [Abstract][Full Text] [Related]
53. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
[TBL] [Abstract][Full Text] [Related]
54. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients.
Roberts TC; Brennan DC; Buller RS; Gaudreault-Keener M; Schnitzler MA; Sternhell KE; Garlock KA; Singer GG; Storch GA
J Infect Dis; 1998 Sep; 178(3):626-35. PubMed ID: 9728529
[TBL] [Abstract][Full Text] [Related]
55. Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.
Potena L; Holweg CT; Vana ML; Bashyam L; Rajamani J; McCormick AL; Cooke JP; Valantine HA; Mocarski ES
J Clin Microbiol; 2007 Jun; 45(6):1804-10. PubMed ID: 17409205
[TBL] [Abstract][Full Text] [Related]
56. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.
Madhavan HN; Priya K
Indian J Ophthalmol; 2003 Mar; 51(1):71-5. PubMed ID: 12701866
[TBL] [Abstract][Full Text] [Related]
57. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
[TBL] [Abstract][Full Text] [Related]
58. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
Loginov R; Höckerstedt K; Lautenschlager I
Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
[TBL] [Abstract][Full Text] [Related]
59. Prospective long-term study on primary CMV infections in adult liver transplant (D+/R-) patients after valganciclovir prophylaxis.
Lautenschlager I; Loginov R; Mäkisalo H; Höckerstedt K
J Clin Virol; 2015 Oct; 71():73-5. PubMed ID: 26318605
[TBL] [Abstract][Full Text] [Related]
60. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
